Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06147258 · ClinicalTrials.gov registry record · NA

The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury

A NA study of Spinal Cord Injuries and Transverse Myelitis, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06147258 is a NA study of Spinal Cord Injuries and Transverse Myelitis that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants, roughly in line with the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06147258, a NA study of Spinal Cord Injuries and Transverse Myelitis, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to evaluate the therapeutic benefits of a 10-week online coach-guided EEWP on psychosocial health among adults with SCI.

Interventions

  • BEHAVIORAL expressive writing

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-05-03
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06147258

The ClinicalTrials.gov registry entry for NCT06147258 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which expressive writing is the first listed.

NCT06147258 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06147258 about?

NCT06147258 is a clinical study titled "The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury". The aim of this study is to evaluate the therapeutic benefits of a 10-week online coach-guided EEWP on psychosocial health among adults with SCI.

What is the current status of trial NCT06147258?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-05-03. Estimated completion is 2026-12-31.

What conditions does trial NCT06147258 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Transverse Myelitis.

What interventions are being tested in trial NCT06147258?

The interventions under investigation include: expressive writing (BEHAVIORAL).

Who is sponsoring clinical trial NCT06147258?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06147258 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.